Hostname: page-component-7d684dbfc8-26pbs Total loading time: 0 Render date: 2023-09-25T17:30:37.010Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "coreDisableSocialShare": false, "coreDisableEcommerceForArticlePurchase": false, "coreDisableEcommerceForBookPurchase": false, "coreDisableEcommerceForElementPurchase": false, "coreUseNewShare": true, "useRatesEcommerce": true } hasContentIssue false

The time course of the immune response to experimental coronavirus infection of man

Published online by Cambridge University Press:  15 May 2009

K. A. Callow
MRC Common Cold Unit, Harvard Hospital, Coombe Road, Salisbury, Wiltshire SP2 8BW, UK
H. F. Parry
Department of Pathology, Salisbury Infirmary, Salisbury, Wiltshire, UK
M. Sergeant
MRC Common Cold Unit, Harvard Hospital, Coombe Road, Salisbury, Wiltshire SP2 8BW, UK
D. A. J. Tyrrell
MRC Common Cold Unit, Harvard Hospital, Coombe Road, Salisbury, Wiltshire SP2 8BW, UK
Rights & Permissions [Opens in a new window]


Core share and HTML view are not possible as this article does not have html content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

After preliminary trials, the detailed changes in the concentration of specific circulating and local antibodies were followed in 15 volunteers inoculated with coronavirus 229E. Ten of them, who had significantly lower concentrations of pre-existing antibody than the rest, became infected and eight of these developed colds. A limited investigation of circulating lymphocyte populations showed some lymphocytopenia in infected volunteers. In this group, antibody concentrations started to increase 1 week after inoculation and reached a maximum about 1 week later. Thereafter antibody titres slowly declined. Although concentrations were still slightly raised 1 year later, this did not always prevent reinfection when volunteers were then challenged with the homologous virus. However, the period of virus shedding was shorter than before and none developed a cold. All of the uninfected group were infected on re-challenge although they also appeared to show some resistance to disease and in the extent of infection. These results are discussed with reference to natural infections with coronavirus and with other infections, such as rhinovirus infections.

Research Article
Copyright © Cambridge University Press 1990



1.Cate, TR, Rossen, RD, Gordon, Douglas R Jr, Butler, WT, Couch, RB. The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol 1966; 84: 352–63.CrossRefGoogle ScholarPubMed
2.Butler, WT, Waldmann, TA, Rossen, RD, Gordon, Douglas R Jr, Couch, RB. Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol 1970; 105: 584–91.Google ScholarPubMed
3.Alford, RH, Rossen, RD, Butler, WT, Kasel, JA. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol 1967; 98: 4724–31.Google ScholarPubMed
4.Rossen, RD, Butler, WT, Waldmann, RH et al. , The proteins in nasal secretion. II A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus. Jama 1970; 211: 1157–61.CrossRefGoogle Scholar
5.Yanagihara, R, Mclntosh, K. Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun 1980; 30: 23–8.Google ScholarPubMed
6.Rossen, RD, Butler, WT, Cate, TR, Szwed, CF, Couch, RB. Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med 1965; 119; 1169–76.CrossRefGoogle ScholarPubMed
7.Crifo, S, Vella, S, Filiaci, F, Resta, S, Rocchi, G. Secretory immune response after nasal vaccination with live attenuated influenza virus. Rhinology 1980; 18: 8792.Google Scholar
8.Holmes, MJ, Reed, SE, Stott, EJ, Tyrrell, DAJ. Studies of experimental rhinovirus type 2 infections in polar isolation and in England. J Hyg 1976; 76; 379–93.CrossRefGoogle ScholarPubMed
9.Buscho, RF, Perkins, JC, Knopf, HLS, Kapikian, AZ, Chanock, RM. Further characterisation of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine. J Immunol 1972; 108: 169–76.Google Scholar
10.Taylor-Robinson, D. Studies on some viruses (rhinoviruses) isolated from common colds. Arch ges Virusforsch 1963; 13: 281–93.CrossRefGoogle ScholarPubMed
11.Barclay, WS, Al-Nakib, W, Higgins, PG, Tyrrell, DAJ. The time course of the humoral immune response to rhinovirus infection. Epidemiol Infect 1990; 103: 659–69.CrossRefGoogle Scholar
12.Callow, KA. Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg 1985; 95: 173–89.CrossRefGoogle ScholarPubMed
13.Macnaughton, MR. Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assay. Infect Immun 1982; 38: 419–23.Google ScholarPubMed
14.Reed, SE. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers. J Med Virol 1984; 13: 179–93.CrossRefGoogle ScholarPubMed
15.Levandowski, RA, Ou, DW, Jackson, GG. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 1986; 153: 743–8.CrossRefGoogle ScholarPubMed
16.Scheinberg, MA, Blacklow, NR, Goldstein, AL, Parrino, TA, Rose, FB, Cathcart, ES. Influenza: response of T-cell lymphopenia to thymosin. New Engl J Med 1976; 294: 1208–11.CrossRefGoogle ScholarPubMed
17.Dolin, R, Richman, DD, Murphy, BR, Fauci, AS. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis 1977; 135: 714–9.CrossRefGoogle ScholarPubMed
18.Faguet, GB. The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes. J Infect Dis 1981; 143: 252–8.CrossRefGoogle ScholarPubMed
19.Aoki, FY, Stiver, HG, Sitar, DS et al. , Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian Forces Personnel 1980–1983. Milit Med 1986; 151: 459–65.CrossRefGoogle ScholarPubMed
20.Beare, AS, Reed, SE. The study of antiviral compounds in volunteers. In: Oxford, JS, ed. Chemoprophylaxis and virus infections of the respiratory tract vol II. Cleveland: CRC Press, 1977; 2755.Google Scholar
21.Higgins, PG, Phillpotts, RJ, Scott, GM, Wallace, J, Bernhardt, LL, Tyrrell, DAJ. Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. Antimicrob Agents Chemother 1983; 24: 713–5.CrossRefGoogle ScholarPubMed
22.Barclay, WS, Callow, KA, Sergeant, M, Al-Nakib, W. Evaluation of an enzyme-linked immunosorbent assay that measures rhinovirus-specific antibodies in human sera and nasal secretions. J Med Virol 1988; 25: 475–82.CrossRefGoogle ScholarPubMed
23.Phillpotts, RJ. Clones of MRC-C cells may be superior to the parent line for the culture of 229E-like strains of human respiratory coronavirus. J Virol Methods 1983; 6: 267–9.CrossRefGoogle Scholar
24.Holmes, MJ, Callow, KA, Parry, HF. An improved method for recovery of secretory immunoglobulins and lymphocytes from the nasal mucosa. Immunol Methods 1987; 48: 183–7.CrossRefGoogle Scholar
25.Lowry, OH, Rosenbrough, NJ, Farr, AL, Randall, RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–75.Google ScholarPubMed
26.Totman, R, Kiff, J, Reed, SE, Craig, JW 1980. Predicting experimental colds in volunteers from different measures of recent life stress. J Psychosom Res 1980; 24: 155–63.CrossRefGoogle ScholarPubMed
27.Broadbent, DE, Broadbent, MHP, Phillpotts, RJ, Wallace, J. Some further studies on the prediction of experimental colds in volunteers by psychological factors. J Psychosom Res 1984; 28: 511–23.CrossRefGoogle ScholarPubMed
28.Larson, HE, Reed, SE, Tyrrell, DAJ. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol 1980; 5: 221–9.CrossRefGoogle ScholarPubMed
29.Tyrrell, DAJ. Common colds and related diseases. London: Edward Arnold, 1965: 8094.Google Scholar
30.Lidwell, OM, Williams, REO. The epidemiology of the common cold I. J Hyg 1961; 59: 309–19.CrossRefGoogle Scholar
31.Cavallaro, JJ, Monto, AS. Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh Michigan. J Infect Dis 1970; 122: 272–9.CrossRefGoogle ScholarPubMed
32.Kaye, HS, Marsh, HB, Dowdle, WR. Seroepidemiologic survey of coronavirus strain OC43 related infections in a children's population. Am J Epidemiol 1971; 94: 43–9.CrossRefGoogle Scholar
33.Monto, AS. Medical reviews: Coronaviruses. Yale J Biol Med 1974; 47: 234–51.Google ScholarPubMed